Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
|colspan="1" style = "font-size:90%;" |'''CD5''' | |colspan="1" style = "font-size:90%;" |'''CD5''' | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 | ||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80<span style="color:#004466;">longer</span> | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 <span style="color:#004466;">longer</span> | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | ||
|- | |- |
Revision as of 19:50, 21 June 2023
Immunophenotype LPD | |||
---|---|---|---|
Marker | CLL | MCL | FL |
κ/λ | 40:80 wk | >80 | 40:80 |
FMC7 | 20:40 wk | 40:80 | 40:80 |
CD5 | >80 | >80 longer | <5% |
CD10 | 5-20 | 5-20 | >80 Stg |
CD11C | 20:40 wk | 20:40 wk | <5% |
CD19 | >80 | >80 | 40:80 |
CD20 | >80 | >80 | >80 |
CD23 | >80 | 5-20 | 40:80 |
CD25 | 20:40 wk | 20:40 wk | 5-20 wk |
CD38 | |||
CD43 | |||
CD79a | wk | ||
CD103 | |||
CD138 | |||
CD200 |
Key to table:
Key to colour code Click for link
Key to expression code Click for link